Investors Met With Slowing Returns on Capital At Evonik Industries (ETR:EVK)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key financial metrics. Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. If you see this, it typically means it's a company with a great business model and plenty of profitable reinvestment opportunities. In light of that, when we looked at Evonik Industries (ETR:EVK) and its ROCE trend, we weren't exactly thrilled.

Advertisement

What Is Return On Capital Employed (ROCE)?

Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. To calculate this metric for Evonik Industries, this is the formula:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.054 = €813m ÷ (€19b - €3.9b) (Based on the trailing twelve months to June 2025).

Thus, Evonik Industries has an ROCE of 5.4%. On its own, that's a low figure but it's around the 6.4% average generated by the Chemicals industry.

See our latest analysis for Evonik Industries

roce
XTRA:EVK Return on Capital Employed September 13th 2025

Above you can see how the current ROCE for Evonik Industries compares to its prior returns on capital, but there's only so much you can tell from the past. If you're interested, you can view the analysts predictions in our free analyst report for Evonik Industries .

So How Is Evonik Industries' ROCE Trending?

Over the past five years, Evonik Industries' ROCE and capital employed have both remained mostly flat. It's not uncommon to see this when looking at a mature and stable business that isn't re-investing its earnings because it has likely passed that phase of the business cycle. With that in mind, unless investment picks up again in the future, we wouldn't expect Evonik Industries to be a multi-bagger going forward. That being the case, it makes sense that Evonik Industries has been paying out 63% of its earnings to its shareholders. Most shareholders probably know this and own the stock for its dividend.

What We Can Learn From Evonik Industries' ROCE

In a nutshell, Evonik Industries has been trudging along with the same returns from the same amount of capital over the last five years. Additionally, the stock's total return to shareholders over the last five years has been flat, which isn't too surprising. On the whole, we aren't too inspired by the underlying trends and we think there may be better chances of finding a multi-bagger elsewhere.

If you'd like to know about the risks facing Evonik Industries, we've discovered 1 warning sign that you should be aware of.

While Evonik Industries isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.

Valuation is complex, but we're here to simplify it.

Discover if Evonik Industries might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About XTRA:EVK

Evonik Industries

Operates as a chemicals company in the Asia-Pacific, Europe, the Middle East, Africa, and the Americas.

Adequate balance sheet average dividend payer.

Advertisement

Weekly Picks

LO
Lou_Basenese
CUE logo
Lou_Basenese on Cue Biopharma ·

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Fair Value:US$7057.9% undervalued
17 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
HE
HedgeY
ASTS logo
HedgeY on AST SpaceMobile ·

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets

Fair Value:US$17044.9% undervalued
36 users have followed this narrative
0 users have commented on this narrative
12 users have liked this narrative
FU
ONTO logo
FundamentalFlow on Onto Innovation ·

Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Fair Value:US$38033.4% undervalued
25 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7447.4% undervalued
57 users have followed this narrative
0 users have commented on this narrative
15 users have liked this narrative

Updated Narratives

QU
QuanD
SPCX logo
QuanD on Space Exploration Technologies ·

Making sense of 1.75 trillion IPO

Fair Value:US$1350% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
MA
SPCX logo
Marek_Trnka on Space Exploration Technologies ·

SpaceX? Only Fast in - Fast out!

Fair Value:US$1350% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
HA
Harshvardhan
IOC logo
Harshvardhan on Indian Oil ·

INDIAN OIL CORPORATION IS THE TITAN IN TRANSITION

Fair Value:₹21435.4% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7447.4% undervalued
57 users have followed this narrative
0 users have commented on this narrative
15 users have liked this narrative
CL
Clive_Thompson
TTWO logo
Clive_Thompson on Take-Two Interactive Software ·

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Fair Value:US$276.9722.6% undervalued
57 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1933.2% undervalued
48 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative